PDGFRA and neoplasm: In addition, none of the PDGF-A-Cre–injected p532lox and LSL-PDGFRα no DOX control mice developed tumors after >80 d post-injection, at which point the experiment was terminated and necropsy performed to validate the absence of tumor (data not shown).